189 related articles for article (PubMed ID: 38671504)
21. Characterization of a new trabectedin-resistant myxoid liposarcoma cell line that shows collateral sensitivity to methylating agents.
Uboldi S; Bernasconi S; Romano M; Marchini S; Fuso Nerini I; Damia G; Ganzinelli M; Marangon E; Sala F; Clivio L; Chiorino G; Di Giandomenico S; Rocchi M; Capozzi O; Margison GP; Watson AJ; Caccuri AM; Pastore A; Fossati A; Mantovani R; Grosso F; Tercero JC; Erba E; D'Incalci M
Int J Cancer; 2012 Jul; 131(1):59-69. PubMed ID: 21805478
[TBL] [Abstract][Full Text] [Related]
22. TLS-CHOP represses miR-486 expression, inducing upregulation of a metastasis regulator PAI-1 in human myxoid liposarcoma.
Borjigin N; Ohno S; Wu W; Tanaka M; Suzuki R; Fujita K; Takanashi M; Oikawa K; Goto T; Motoi T; Kosaka T; Yamamoto K; Kuroda M
Biochem Biophys Res Commun; 2012 Oct; 427(2):355-60. PubMed ID: 22995304
[TBL] [Abstract][Full Text] [Related]
23. Relevance of translocation type in myxoid liposarcoma and identification of a novel EWSR1-DDIT3 fusion.
Bode-Lesniewska B; Frigerio S; Exner U; Abdou MT; Moch H; Zimmermann DR
Genes Chromosomes Cancer; 2007 Nov; 46(11):961-71. PubMed ID: 17647282
[TBL] [Abstract][Full Text] [Related]
24. FUS-DDIT3 Fusion Oncoprotein Expression Affects JAK-STAT Signaling in Myxoid Liposarcoma.
Dolatabadi S; Jonasson E; Andersson L; Luna Santamaría M; Lindén M; Österlund T; Åman P; Ståhlberg A
Front Oncol; 2022; 12():816894. PubMed ID: 35186752
[TBL] [Abstract][Full Text] [Related]
25. Liposarcomas in young patients: a study of 82 cases occurring in patients younger than 22 years of age.
Alaggio R; Coffin CM; Weiss SW; Bridge JA; Issakov J; Oliveira AM; Folpe AL
Am J Surg Pathol; 2009 May; 33(5):645-58. PubMed ID: 19194281
[TBL] [Abstract][Full Text] [Related]
26. The utility of fluorescence in situ hybridization (FISH) in the diagnosis of myxoid soft tissue neoplasms.
Downs-Kelly E; Goldblum JR; Patel RM; Weiss SW; Folpe AL; Mertens F; Hartke M; Tubbs RR; Skacel M
Am J Surg Pathol; 2008 Jan; 32(1):8-13. PubMed ID: 18162764
[TBL] [Abstract][Full Text] [Related]
27. The FUS::DDIT3 fusion oncoprotein inhibits BAF complex targeting and activity in myxoid liposarcoma.
Zullow HJ; Sankar A; Ingram DR; Samé Guerra DD; D'Avino AR; Collings CK; Lazcano R; Wang WL; Liang Y; Qi J; Lazar AJ; Kadoch C
Mol Cell; 2022 May; 82(9):1737-1750.e8. PubMed ID: 35390276
[TBL] [Abstract][Full Text] [Related]
28. Establishment and characterization of a new human myxoid liposarcoma cell line (DL-221) with the FUS-DDIT3 translocation.
de Graaff MA; Yu JS; Beird HC; Ingram DR; Nguyen T; Juehui Liu J; Bolshakov S; Szuhai K; Åman P; Torres KE; Lev D; Nielsen TO; Bovée JV; Lazar AJ; Somaiah N
Lab Invest; 2016 Aug; 96(8):885-94. PubMed ID: 27270875
[TBL] [Abstract][Full Text] [Related]
29. A Low-Grade Myxoid Liposarcoma Arising in a Deep-Seated Conventional Lipoma.
Tsagkozis P; Haglund F
Int J Surg Pathol; 2019 Dec; 27(8):919-922. PubMed ID: 31218893
[TBL] [Abstract][Full Text] [Related]
30. Gene of the month: DDIT3.
Diaz-Perez JA; Kerr DA
J Clin Pathol; 2024 Mar; 77(4):211-216. PubMed ID: 38053287
[TBL] [Abstract][Full Text] [Related]
31. Myxoid liposarcoma with pleomorphic cells: Report of two cases with molecular confirmation of FUS gene rearrangements.
Uchihashi K; Matsuyama A; Nakayama M; Sakamoto A; Shiba E; Hisaoka M
Pathol Res Pract; 2016 Nov; 212(11):1067-1070. PubMed ID: 27515548
[TBL] [Abstract][Full Text] [Related]
32. Trabectedin (ET-743) promotes differentiation in myxoid liposarcoma tumors.
Forni C; Minuzzo M; Virdis E; Tamborini E; Simone M; Tavecchio M; Erba E; Grosso F; Gronchi A; Aman P; Casali P; D'Incalci M; Pilotti S; Mantovani R
Mol Cancer Ther; 2009 Feb; 8(2):449-57. PubMed ID: 19190116
[TBL] [Abstract][Full Text] [Related]
33. A mechanistic study on the metastasis inducing function of FUS-CHOP fusion protein in liposarcoma.
Patil N; Ahmed Kabeer Rasheed S; Abba M; Hendrik Leupold J; Schwarzbach M; Allgayer H
Int J Cancer; 2014 Jun; 134(12):2808-19. PubMed ID: 24285420
[TBL] [Abstract][Full Text] [Related]
34. DDIT3 gene break-apart as a molecular marker for diagnosis of myxoid liposarcoma--assay validation and clinical experience.
Narendra S; Valente A; Tull J; Zhang S
Diagn Mol Pathol; 2011 Dec; 20(4):218-24. PubMed ID: 22089349
[TBL] [Abstract][Full Text] [Related]
35. Radiation-Induced Phosphorylation of a Prion-Like Domain Regulates Transformation by FUS-CHOP.
Chen M; Foster JP; Lock IC; Leisenring NH; Daniel AR; Floyd W; Xu E; Davis IJ; Kirsch DG
Cancer Res; 2021 Oct; 81(19):4939-4948. PubMed ID: 34385184
[TBL] [Abstract][Full Text] [Related]
36. FUS-CHOP fusion protein expression coupled to p53 deficiency induces liposarcoma in mouse but not in human adipose-derived mesenchymal stem/stromal cells.
Rodriguez R; Rubio R; Gutierrez-Aranda I; Melen GJ; Elosua C; García-Castro J; Menendez P
Stem Cells; 2011 Feb; 29(2):179-92. PubMed ID: 21732477
[TBL] [Abstract][Full Text] [Related]
37. Myxoid liposarcoma with cartilaginous differentiation: identification of the same type II TLS-CHOP fusion gene transcript in both lipogenic and chondroid components.
Wei YC; Li CF; Eng HL; Yeh MC; Lin CN; Huang HY
Appl Immunohistochem Mol Morphol; 2007 Dec; 15(4):477-80. PubMed ID: 18091394
[TBL] [Abstract][Full Text] [Related]
38. [Detection of FUS-CHOP fusion gene in paraffin-embedded tissues and its clinicopathologic significance for myxoid/round cell liposarcomas].
Xiang H; Wang J; Sun MH; Lu L; Shui RH; Zhu XZ
Zhonghua Bing Li Xue Za Zhi; 2005 Jan; 34(1):28-32. PubMed ID: 15796878
[TBL] [Abstract][Full Text] [Related]
39. Detection of myxoid liposarcoma-associated FUS-DDIT3 rearrangement variants including a newly identified breakpoint using an optimized RT-PCR assay.
Powers MP; Wang WL; Hernandez VS; Patel KS; Lev DC; Lazar AJ; López-Terrada DH
Mod Pathol; 2010 Oct; 23(10):1307-15. PubMed ID: 20581806
[TBL] [Abstract][Full Text] [Related]
40. Abnormal expression of cell cycle regulators in FUS-CHOP carrying liposarcomas.
Olofsson A; Willén H; Göransson M; Engström K; Meis-Kindblom JM; Stenman G; Kindblom LG; Aman P
Int J Oncol; 2004 Nov; 25(5):1349-55. PubMed ID: 15492825
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]